IRVINE, Calif. (PRWEB)
September 27, 2022
StudyKIK today announced that the company will be taking part in the Society for Clinical Research Sites (SCRS) Site Solutions Summit, October 7 – 9 in Hollywood, Florida. They will be showcasing their suite of clinical trial technologies at the event that highlights the importance of site sustainability and the impact sites have on clinical research.
StudyKIK will be presenting the Site Patient Recruitment Innovation Award, an award that recognizes sites utilizing innovative strategies to achieve enrollment success. “It’s an honor to both judge and present this year’s Site Patient Recruitment Innovation Award,” said Tarra Shingler, SVP of Global Business Solutions, “at StudyKIK, we recognize the instrumental role sites play in clinical research and we are excited to continue to show our support for the clinical research site community.”
Shingler will also be presenting a breakout session titled “Social Media: Marketing on Facebook, Instagram, Twitter, Tik Tok, and More. A session on patient recruitment and retention”. The presentation will discuss leveraging social media to advance sites goals, different types of social media marketing opportunities that are available to sites and how to use them in partnership with sponsors, CROs and IRBs to present studies and sites in new and creative ways. The session will take place on Saturday, October 8 from 3:00PM – 4:00PM.
About StudyKIK
StudyKIK is the leading provider of clinical trial recruitment and retention technologies for patients, sites, and sponsors. Founded in 2014, StudyKIK has demonstrated improved quality and accelerated enrollment timelines in certain clinical trials by up to 94%. With a mission to make a difference in the world by bringing new treatments to people faster through education and innovative technology, StudyKIK continues to develop new technology-enabled, insight-powered solutions to help support clinical research. For more information visit http://www.studykik.com.
Share article on social media or email: